Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Novartis
Novartis
Novelty Nobility, Inc.
Deciphera Pharmaceuticals, LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center